B-Cell Receptor-Associated Protein 31 (BCAP31) (Middle Region) Peptide
BCAP31
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN5512164
Quick Overview for B-Cell Receptor-Associated Protein 31 (BCAP31) (Middle Region) Peptide (ABIN5512164)
Target
BCAP31
(B-Cell Receptor-Associated Protein 31 (BCAP31))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Sequence
- LASNEAFKKQ AESASEAAKK YMEENDQLKK GAAVDGGKLD VGNAEVKLEE
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti- BCAP31 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- BCAP31 (B-Cell Receptor-Associated Protein 31 (BCAP31))
-
Background
-
This gene encodes a member of the B-cell receptor associated protein 31 superfamily. The encoded protein is a multi-pass transmembrane protein of the endoplasmic reticulum that is involved in the anterograde transport of membrane proteins from the endoplasmic reticulum to the Golgi and in caspase 8-mediated apoptosis. Microdeletions in this gene are associated with contiguous ABCD1/DXS1375E deletion syndrome (CADDS), a neonatal disorder. Alternative splicing of this gene results in multiple transcript variants. Two related pseudogenes have been identified on chromosome 16.
Alias Symbols: CDM, DDCH, BAP31, 6C6-AG, DXS1357E
Protein Size: 246 -
Gene ID
- 10134
-
NCBI Accession
- NM_001139441, NP_001132913
-
UniProt
- P51572
Target
-
You are here:
